Regulated content, without the wait.

QUIPMLR FOR MLR REVIEW

Pre-screens content against claims libraries and prior rulings, cutting MLR review cost and time by 70%. Platform-agnostic, human sign-off.

QUIPTAG: METADATA AT FORTUNE 100 SCALE

AI metadata authoring for AEM Assets: up to 80% faster tagging across thousands of assets at a Fortune 100 pharmaceutical company, into Adobe Analytics and CJA.

KORUIQ PROTECTS MEDIA SPEND

Observability across data integrity, tags, and media delivery. KoruIQ identified $4M per year in recoverable media spend at a Fortune 100 pharma.

AI GOVERNANCE FOR REGULATED WORKFLOWS

Approval gates, non-destructive scopes, credential isolation, and allowlists let legal, IT, and compliance say yes to AI.

CLAUDE READINESS ASSESSMENT (FROM $15,000)

A 4–6 week, fixed-scope engagement: executive alignment, prioritized AI use cases with ROI, a governance model MLR and IT can review, and a 90-day plan.

WHY FIXED SCOPE MATTERS IN PHARMA

The FrontRow methodology keeps every stage fixed-fee and gated, so procurement, legal, and compliance approve a bounded step.

SAVED

70%

Of Medical-Legal-Regulatory review cost and time with QuipMLR

Every gate still carries human sign-off. QuipTag delivers up to 80% faster metadata tagging on the same estate.

QuipMLR applies agentic AI to Medical-Legal-Regulatory review and cuts review cost and time by 70%. It pre-screens promotional and medical content against claims libraries, reference packages, and prior rulings before human reviewers see it, so committees spend their time on judgment calls rather than mechanical checks. QuipMLR is platform-agnostic and was built by NextRow, an Anthropic Claude Certified Partner.

Yes. QuipTag for AEM delivered up to 80% faster metadata tagging at a Fortune 100 pharmaceutical company, across thousands of assets. It authors metadata inside Adobe Experience Manager Assets and connects to Adobe Analytics and Customer Journey Analytics, so tagging quality shows up downstream in search, reuse, and reporting.

Every NextRow agent runs inside an explicit governance model: approval gates before consequential actions, non-destructive operating scopes, credential isolation, and system allowlists. That model is documented for legal and IT review as part of every engagement, and NextRow, as an Anthropic Claude Certified Partner, aligns deployments with Anthropic usage policies.

KoruIQ is NextRow's MarTech observability platform. It monitors data integrity, tags, and media delivery across your marketing stack. At a Fortune 100 pharmaceutical company, KoruIQ identified $4M per year in recoverable media spend by catching broken tracking and misfiring tags before budgets were wasted.

Engagements start with the FrontRow assessment stage. For pharma teams that usually means a Claude Readiness Assessment, a fixed-scope engagement from $15,000 that runs 4 to 6 weeks. It ends with prioritized use cases with ROI, a governance model your compliance team can review, and a 90-day plan.

No. NextRow publishes pharma results anonymized by policy, such as up to 80% faster tagging and $4M per year in recoverable media spend at a Fortune 100 pharmaceutical company. The numbers are documented from real engagements; the names stay confidential.